Ly-GDI Antibodies

Santa Cruz Biotechnology features a diverse variety of Ly-GDI monoclonal antibodies for research focused on understanding Ly-GDI protein function. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Ly-GDI, or Lysozyme Guanine Nucleotide Dissociation Inhibitor, plays a crucial role in regulating the activity of Rho family GTPases, which are essential for various cellular processes, including cell migration, proliferation, and differentiation. By modulating the signaling pathways of GTPases, Ly-GDI is vital for maintaining cellular homeostasis and responding to external stimuli. Understanding Ly-GDI function is important for elucidating its involvement in various diseases, including cancer and neurodegenerative disorders. Researchers worldwide rely on Ly-GDI monoclonal antibodies to advance their studies of cellular signaling pathways. Current investigations utilizing Ly-GDI monoclonal antibodies continue to reveal new insights about cellular regulation mechanisms. Santa Cruz Biotechnology monoclonal antibodies for Ly-GDI research support scientists in making meaningful contributions to understanding disease mechanisms and potential therapeutic approaches.